Dr. Heather R. Reyerson, DDS in La Crosse, Wisconsin
-
Aurora Sheboygan Prices – PROPOFOL 10 MG/ML IV EMUL(WRAPPED) is $78.06
At Aurora Medical Center Sheboygan, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10002800, regarding PROPOFOL 10 MG/ML IV EMUL(WRAPPED), which is classified under revenue code 250 and associated with CPT code J2704, the designated fee stands at $78.06. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Aurora Sheboygan Prices – PORPHYRINS FECES QUANT is $265
At Aurora Medical Center Sheboygan, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10001077, regarding PORPHYRINS FECES QUANT, which is classified under revenue code 301 and associated with CPT code 84126, the designated fee stands at $265. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Aurora Sheboygan Prices – RH IMMUNE GLOBULIN, 300 UG is $395
At Aurora Medical Center Sheboygan, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10004736, regarding RH IMMUNE GLOBULIN, 300 UG, which is classified under revenue code 250 and associated with CPT code J2790, the designated fee stands at $395. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Latest Treatments for Heart Disease: Advances Patients Need to Know
This article breaks down the most important new options for treating heart disease—and what they mean for you. It explains how newer medications (such as SGLT2 inhibitors, PCSK9 inhibitors, and select GLP-1 therapies), minimally invasive procedures (including transcatheter valve repair/replacement, advanced stents, and left atrial appendage closure), and better tools for diagnosis, remote monitoring, and cardiac rehabilitation can improve outcomes and recovery time. Designed for patients and caregivers, it translates current evidence into clear takeaways: who might benefit, what to expect before and after treatment, potential risks, costs and access, and key questions to ask your care team—so you can make informed, confident decisions together.
